Skip to main content
Log in

Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Lipoprotein lipase (LPL) is the rate-limiting enzyme in the hydrolysis of triglyceride-rich lipoprotein particles (Chylomicrons and very-low-density lipoprotein). LPL polymorphisms’ effects on lipids and coronary artery disease are controversial among studies and populations. Our aim was to study the association between six polymorphisms, haplotypes and significant coronary stenosis (SCS), disease severity and lipid parameters in Tunisian patients. LPL PvuII, 93 T/G, 188 G/E, HindIII, N291S and D9N polymorphisms were analyzed in 316 patients who underwent coronary angiography. Assessment of coronary angiograms identified SCS as the presence of stenosis >50 % in at least one major coronary artery. The stenosis severity was determined by using Gensini score and vessels number. A significant association of SCS with TT of the HindIII polymorphism was showed (odds ratio (OR): 2.84, 95 % CI, 1.19–7.40, p = 0.017) and TG (OR: 1.77, 95 % CI, 1.99–2.82, p = 0.033). The mutated HindIII genotype was significantly associated with increased TG and ApoB/ApoA-I ratio and with decreased HDL-C. Haplotype analysis showed that OR of SCS associated with the CTGTAG haplotype was 2.12 (95 % CI 1.05–4.25, p = 0.032) and with CGGGAA was 0.71 (95 % CI 0.26–1.95, p = 0.022) compared to the CTGTAA. Significant difference in Gensini score was observed among HindIII genotype and haplotypes. A significant association between the mutated genotype of HindIII polymorphism and decreased HDL-C level and increased ApoB/ApoA-I ratio and TG level was showed. Our results suggest that HindIII and D9N polymorphisms and CTGTAG haplotype seem to be considered as marker of predisposition to coronary stenosis. In another hand, HindIII and haplotypes were related to stenosis severity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ben romdhane H, Bougatef S, Skhiri H, Gharbi D, Kafsi MN, Belhani A et al (2004) The first Tunisian cardiovascular diseases register: processes and results. Revue d’épidémiologie ET de santé publique 52:558–564

    Article  PubMed  CAS  Google Scholar 

  2. Miller GJ, Miller NE (1975) Plasma high density lipoprotein concentration and development of ischaemic heart-disease. Lancet 1:16–25

    Article  PubMed  CAS  Google Scholar 

  3. Goldbourt U, Yaaari S, Medalie JH (1997) Isolated low HDL cholesterol as a risk factor for coronary heart disease. Arterioscler Thromb Vasc Biol 17:107–113

    Article  PubMed  CAS  Google Scholar 

  4. Stephens JW, Humphries SE (2003) The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 253:120–127

    Article  PubMed  CAS  Google Scholar 

  5. Chen Q, Razzaghi H, Demirci FY, Kamboh MI (2008) Functional significance of lipoprotein lipase HindIII. Atherosclerosis 200:102–108

    Article  PubMed  CAS  Google Scholar 

  6. Kussi T, Ehnholm C, Viikari J, Harkonen R, Vartiainen E, Puska P et al (1989) Postheparin plasma lipoprotein and hepatic lipase are determinants of hypoalphalipoproteinemia and hyperalphalipoproteinemia. J Lipid Res 30:1117–1126

    Google Scholar 

  7. Patsch JR, Prasad S, Gotto AM, Patsh W (1987) High density lipoprotein2- relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80:341–347

    Article  PubMed  CAS  Google Scholar 

  8. Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J et al (1999) Association of lipoprotein lipase gene polymorphisms with coronary artery disease. J Am Coll Cardiol 33:1013–1020

    Article  PubMed  CAS  Google Scholar 

  9. Su Z, Zhang S, Hou Y, Zhang Li, Liao L, Xiao C (2002) Relationship between a novel polymorphism of lipoprotein lipase gene and coronary heart disease. Chin Med J (EngI) 115:677–680

    CAS  Google Scholar 

  10. Goldberg IJ (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenisis. J Lipid Res 37:693–707

    PubMed  CAS  Google Scholar 

  11. Olivecrona G, Olivecrona T (1995) Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 6:291–305

    Article  PubMed  CAS  Google Scholar 

  12. Sagoo GS, Tatt I, Salanti G, Butterworth AS, Sarwar N, Maarle Mv et al (2008) Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol 168:1233–1246

    Article  PubMed  Google Scholar 

  13. Goodarzi MO, Wong H, Quinones MJ, Taylor KD, Guo X, Castellani LW, Antoine HJ, Yang H, Hsueh WA, Rotter JI (2005) The 3’ untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity. J Clin Endocrinol Metab 90:4816–4823

    Google Scholar 

  14. Emi M, Wilson DE, Iverius PH, Wu L, Hata A, Hegele R, Williams RR, Lalouel JM (1990) Missense mutation (Gly → Glu 188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem 10:5910–5916

    Google Scholar 

  15. Hallman DM, Groenemeijer BE, Jukema JW, Boerwinkle E, Kastelein JJ (1999) Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci. Annals of human genetics. Ann Hum Genet 63:499-510.

    Google Scholar 

  16. Wang XL, Tam C, McCredie RM, Wilcken DEL (1994) Determinants of severity of coronary artery disease in Australian men and women. Circulation 89:1974–1981

    Article  PubMed  CAS  Google Scholar 

  17. Hu Y, Liu W, Huang R, Zhang X (2006) A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 47:1908–1914

    Article  PubMed  CAS  Google Scholar 

  18. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG (1999) Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99:2901–2907

    Article  PubMed  CAS  Google Scholar 

  19. Zhang R, Liu Y, Yang LC, Bai H, Liu BW (2003) Study on lipoprotein lipase gene HindIII polymorphism in Chinese type IIb hyperlipoproteinemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20:539–541

    PubMed  CAS  Google Scholar 

  20. Socquard E, Durlach A, Clavel C, Nazeyrollas P, Durlach V (2006) Association of HindIII and PvuII genetic polymorphisms of lipoprotein lipase with lipid metabolism and macrovascular events in type 2 diabetic patients. Diabetes Metab 32:262–269

    Article  PubMed  CAS  Google Scholar 

  21. Gigek Cde O, Chen ES, Cendoroglo MS, Ramos LR, Araujo LM, Payão SL et al (2007) Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels. Clin Chem Lab Med 45:599–604

    Article  PubMed  Google Scholar 

  22. McGladdery SH, Pimstone SN, Clee SM, Bowden JF, Hayden MR, Frohlich JJ (2001) Common mutations in the lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in a Chinese Canadian population. Atherosclerosis 156:401–407

    Article  PubMed  CAS  Google Scholar 

  23. Brousseau ME, Goldkamp AL, Collins D, Demissie S, Connolly AC, Cupples CA et al (2004) Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial. J Lipid Res 45:1885–1891

    Article  PubMed  CAS  Google Scholar 

  24. Van Bockxmeer FM, Liu Q, Mamotte C, Burke V, Taylor R (2001) Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis 157:123–129

    Article  PubMed  Google Scholar 

  25. Ferencak G, Pasalic D, Grskovic B, Cheng S, Fijal B, Sesto M et al (2003) Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease. Clin Chem Lab Med 41:541–546

    Article  PubMed  CAS  Google Scholar 

  26. Abu-Amero KK, Wyngaard CA, AI-Boudari OM, Kambouris M, Dzimiri N (2003) Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population. Arch Pathol Lab Med 127:597–600

    PubMed  CAS  Google Scholar 

  27. Wang XL, McCredie RM, Wilcken DE (1996) Common DNA polymorphisms at the lipoprotein lipase gene: association with severity of coronary artery disease and diabetes. Circulation 93:1339–1345

    Article  PubMed  CAS  Google Scholar 

  28. Rejeb J, Omezzine A, Rebhi L, Naffeti I, Kchok K, Belkahla R et al (2008) Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population. Arch Cardiovasc Dis 101:629–636

    Article  PubMed  Google Scholar 

  29. Gensini Goffredo G (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606

    Article  PubMed  CAS  Google Scholar 

  30. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

    PubMed  CAS  Google Scholar 

  31. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  32. Lowontin RC (1984) The interaction of selection and linkage 1. General considerations: heterotic models. Genetics 49:49–67

    Google Scholar 

  33. Greeland S, Rothman KJ (1998) Introduction to stratified analysis. In: Williams A, Wilkins B (eds) Modern epidemiology. Lippincott, Philadelphia, PA, pp 253–279

    Google Scholar 

  34. Shagisultanova EI, Mustafina OE, Tuktarova IA, Khusnutdinova EK (2001) HindIII polymorphism of lipoprotein lipase gene and risk of myocardial infarction. Mol Gen Mikrobiol Virusol 3:18–22

    PubMed  Google Scholar 

  35. Minich A, Kessling A, Roy M, Giry C, Delangavant G, Lavigne J et al (1995) Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J Lipid Res 36:117–124

    Google Scholar 

  36. Arca M, Campagna F, Montali A, Barillã F, Mangicri E, Tanzilli G et al (2000) The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis. Clin Genet 58:369–374

    Article  PubMed  CAS  Google Scholar 

  37. Thorn JA, Chamberlain JC, Alcolando JC, Oka K, Chan L, Stocks J et al (1990) Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 85:55–60

    Article  PubMed  CAS  Google Scholar 

  38. Malygina NA, Kostomarova IV, Deriagin GV, Serova LD (2002) HindIII DNA-polumorphism of lipoprotein lipase gene in elderly patients with ischemic heart disease. Ter Arkh 74:64–66

    PubMed  CAS  Google Scholar 

  39. Gerdes C, Gerdes LU, Hansen PS, Faergeman O (1995) Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 92:1765–1769

    Article  PubMed  CAS  Google Scholar 

  40. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D et al (1995) Lipoprotein lipase gene polymorphism: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude cas Témoin sur l’infarctus du Myocarde. J Lipid Res 36:2141–2146

    PubMed  CAS  Google Scholar 

  41. Talmud PJ, Bujac SR, Hall S, Miller GJ, Humphries SE (2000) Substitution of asparagines for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischemic heart disease in males smokers. Atherosclerosis 149:75–81

    Article  PubMed  CAS  Google Scholar 

  42. Yang Y, Ruiz-Narvaez E, Niu T, Xu X, Campos H (2004) Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 45:2106–2109

    Article  PubMed  CAS  Google Scholar 

  43. Ma YQ, Thomas GN, Ng MC, Critchley JA, Chan JC, Tomlinson B (2003) The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients. Metabolism 52:338–343

    Article  PubMed  CAS  Google Scholar 

  44. Razzaghi H, Aston CE, Hamman RF, Kamboh MI (2000) Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 107:257–267

    Article  PubMed  CAS  Google Scholar 

  45. Hall S, Talmud PJ, Cook DG, Wicks PD, Rothwell MJ, Strazzullo P et al (2000) Frequency and allelic associations of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study. Genet Epidemiol 18:203–216

    Article  PubMed  CAS  Google Scholar 

  46. Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M et al (2001) Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke 32:14–81

    Article  Google Scholar 

Download references

Acknowledgments

We are especially grateful to the study participants. We acknowledge the technical assistance of staff members of the Biochemistry and Cardiology Departments. This study was supported by grants from the Tunisian ministry of Higher Education, Scientific Research, and Technology, and the Ministry of Health (UR 26/04).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Bouslama.

Additional information

Lamia Rebhi and Kaouther Kchock have equally contributed to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 38 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rebhi, L., Kchok, K., Omezzine, A. et al. Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population. Mol Biol Rep 39, 9893–9901 (2012). https://doi.org/10.1007/s11033-012-1856-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1856-9

Keywords

Navigation